Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30988% above fair value
$32.16+2.64 (+8.94%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Harrow shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Harrow's shares outstanding was 37M at Jun 30, 2026. For fiscal 2025 it was 37M, up 3.1% from the year before. Over ten years it grew 14.4% a year on average. The highest annual figure on record is 37M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37M | +3.1% |
| FY2024 | Dec 31, 2024 | 36M | +9.3% |
| FY2023 | Dec 31, 2023 | 33M | +18.8% |
| FY2022 | Dec 31, 2022 | 27M | +2.6% |
| FY2021 | Dec 31, 2021 | 27M | +3.3% |
| FY2020 | Dec 31, 2020 | 26M | -2.2% |
| FY2019 | Dec 31, 2019 | 26M | +11.1% |
| FY2018 | Dec 31, 2018 | 24M | +18.9% |
| FY2017 | Dec 31, 2017 | 20M | +57.2% |
| FY2016 | Dec 31, 2016 | 13M | +33.1% |
| FY2015 | Dec 31, 2015 | 10M | +4.9% |
| FY2014 | Dec 31, 2014 | 9M | +5.5% |
| FY2013 | Dec 31, 2013 | 9M | +92.7% |
| FY2012 | Dec 31, 2012 | 4M | +1029.6% |
| FY2011 | Dec 31, 2011 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 37M | -3.9% |
| Q1 FY2026 | Mar 31, 2026 | 37M | +3.9% |
| Q4 FY2025 | Dec 31, 2025 | 37M | +4.1% |
| Q3 FY2025 | Sep 30, 2025 | 39M | +8.9% |
| Q2 FY2025 | Jun 30, 2025 | 39M | +9.1% |
| Q1 FY2025 | Mar 31, 2025 | 36M | +1.0% |
| Q4 FY2024 | Dec 31, 2024 | 36M | +1.2% |
| Q3 FY2024 | Sep 30, 2024 | 36M | +4.2% |
| Q2 FY2024 | Jun 30, 2024 | 36M | +16.9% |
| Q1 FY2024 | Mar 31, 2024 | 35M | +17.1% |
| Q4 FY2023 | Dec 31, 2023 | 35M | +26.6% |
| Q3 FY2023 | Sep 30, 2023 | 34M | +25.2% |
| Q2 FY2023 | Jun 30, 2023 | 30M | +11.6% |
| Q1 FY2023 | Mar 31, 2023 | 30M | +11.2% |
| Q4 FY2022 | Dec 31, 2022 | 28M | +3.0% |
| Q3 FY2022 | Sep 30, 2022 | 27M | +0.9% |
| Q2 FY2022 | Jun 30, 2022 | 27M | +2.1% |
| Q1 FY2022 | Mar 31, 2022 | 27M | -0.9% |
| Q4 FY2021 | Dec 31, 2021 | 27M | +4.7% |
| Q3 FY2021 | Sep 30, 2021 | 27M | +0.1% |
| Q2 FY2021 | Jun 30, 2021 | 27M | +3.3% |
| Q1 FY2021 | Mar 31, 2021 | 27M | +6.2% |
| Q4 FY2020 | Dec 31, 2020 | 26M | -14.2% |
| Q3 FY2020 | Sep 30, 2020 | 27M | +5.9% |
| Q2 FY2020 | Jun 30, 2020 | 26M | +2.7% |
| Q1 FY2020 | Mar 31, 2020 | 26M | -2.7% |
| Q4 FY2019 | Dec 31, 2019 | 30M | -3.7% |
| Q3 FY2019 | Sep 30, 2019 | 26M | +17.8% |
| Q2 FY2019 | Jun 30, 2019 | 25M | +8.8% |
| Q1 FY2019 | Mar 31, 2019 | 27M | +26.9% |
| Q4 FY2018 | Dec 31, 2018 | 31M | +51.8% |
| Q3 FY2018 | Sep 30, 2018 | 22M | +7.1% |
| Q2 FY2018 | Jun 30, 2018 | 23M | -0.0% |
| Q1 FY2018 | Mar 31, 2018 | 21M | +10.7% |
| Q4 FY2017 | Dec 31, 2017 | 21M | +50.4% |
| Q3 FY2017 | Sep 30, 2017 | 20M | +50.5% |
| Q2 FY2017 | Jun 30, 2017 | 23M | – |
| Q1 FY2017 | Mar 31, 2017 | 19M | – |
| Q4 FY2016 | Dec 31, 2016 | 14M | – |
| Q3 FY2016 | Sep 30, 2016 | 13M | – |
See a number that looks wrong?